<DOC>
	<DOC>NCT01392820</DOC>
	<brief_summary>The purpose of this study is to assess safety, tolerability and pharmacokinetics of TC-5214 in elderly healthy Japanese volunteers.</brief_summary>
	<brief_title>A Study of Single and Multiple Ascending Doses of TC-5214 in Japanese Healthy Elderly Male and Female Volunteers</brief_title>
	<detailed_description />
	<criteria>Japanese healthy elderly male and female ≥65 years old. Have a BMI of ≥18 and ≤27 kg/m2 and weigh ≥ 45 kg. Be able to understand and comply with the requirements of the study as judged by the investigator(s). History of any clinically significant medical or neurologic disease or disorder. History of gastrointestinal surgery or unintentional rapid weight loss. Any clinically significant illness, medical/surgical procedure or trauma within 4 weeks of the first administration of the study drug.</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Phase I</keyword>
	<keyword>Japan</keyword>
	<keyword>Elderly</keyword>
	<keyword>PK</keyword>
	<keyword>SAD</keyword>
	<keyword>MAD</keyword>
</DOC>